About Quarterly Earnings Report Disclosures
| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥33.60B | ¥30.54B | +10.0% |
| Cost of Sales | ¥29.05B | ¥26.30B | +10.4% |
| Gross Profit | ¥4.55B | ¥4.24B | +7.4% |
| SG&A Expenses | ¥4.16B | ¥4.14B | +0.4% |
| Operating Income | ¥399M | ¥100M | +299.0% |
| Non-operating Income | ¥72M | ¥60M | +20.0% |
| Non-operating Expenses | ¥143M | ¥132M | +8.3% |
| Ordinary Income | ¥328M | ¥29M | +1031.0% |
| Profit Before Tax | ¥368M | ¥34M | +982.4% |
| Income Tax Expense | ¥261M | ¥156M | +67.3% |
| Net Income | ¥106M | ¥-121M | +187.6% |
| Net Income Attributable to Owners | ¥111M | ¥-113M | +198.2% |
| Total Comprehensive Income | ¥100M | ¥-125M | +180.0% |
| Depreciation & Amortization | ¥378M | ¥339M | +11.5% |
| Interest Expense | ¥123M | ¥68M | +80.9% |
| Basic EPS | ¥9.75 | ¥-10.09 | +196.6% |
| Diluted EPS | ¥9.37 | - | - |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥11.56B | ¥13.24B | ¥-1.68B |
| Cash and Deposits | ¥2.56B | ¥4.91B | ¥-2.36B |
| Accounts Receivable | ¥738M | ¥738M | ¥0 |
| Inventories | ¥4.60B | ¥4.07B | +¥531M |
| Non-current Assets | ¥18.40B | ¥18.68B | ¥-288M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-220M | ¥-200M | ¥-20M |
| Financing Cash Flow | ¥-1.67B | ¥1.14B | ¥-2.80B |
| Item | Value |
|---|---|
| Net Profit Margin | 0.3% |
| Gross Profit Margin | 13.6% |
| Current Ratio | 102.4% |
| Quick Ratio | 61.7% |
| Debt-to-Equity Ratio | 3.38x |
| Interest Coverage Ratio | 3.24x |
| EBITDA Margin | 2.3% |
| Effective Tax Rate | 70.9% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +10.0% |
| Operating Income YoY Change | +296.3% |
| Ordinary Income YoY Change | -95.8% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 12.06M shares |
| Treasury Stock | 558K shares |
| Average Shares Outstanding | 11.41M shares |
| Book Value Per Share | ¥594.13 |
| EBITDA | ¥777M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥14.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| CosmeticDrugAndConvenienceStore | ¥4.08B | ¥-21M |
| CustodyOfMedicalDocuments | ¥322M | ¥43M |
| DispensingPharmacy | ¥28.48B | ¥589M |
| MedicalMall | ¥257M | ¥48M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥66.80B |
| Operating Income Forecast | ¥1.12B |
| Ordinary Income Forecast | ¥941M |
| Net Income Attributable to Owners Forecast | ¥266M |
| Basic EPS Forecast | ¥23.45 |
| Dividend Per Share Forecast | ¥14.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
| Property, Plant & Equipment | ¥7.29B | ¥7.21B | +¥85M |
| Intangible Assets | ¥6.88B | ¥7.27B | ¥-383M |
| Goodwill | ¥6.48B | ¥6.80B | ¥-323M |
| Total Assets | ¥29.96B | ¥31.92B | ¥-1.97B |
| Current Liabilities | ¥11.28B | ¥11.99B | ¥-704M |
| Accounts Payable | ¥6.33B | ¥6.65B | ¥-312M |
| Non-current Liabilities | ¥11.84B | ¥13.02B | ¥-1.18B |
| Long-term Loans | ¥9.87B | ¥11.05B | ¥-1.18B |
| Total Liabilities | ¥23.12B | ¥25.00B | ¥-1.88B |
| Total Equity | ¥6.83B | ¥6.92B | ¥-84M |
| Capital Stock | ¥1.96B | ¥1.96B | ¥0 |
| Capital Surplus | ¥2.09B | ¥2.19B | ¥-95M |
| Retained Earnings | ¥2.89B | ¥2.94B | ¥-48M |
| Treasury Stock | ¥-376M | ¥-471M | +¥95M |
| Owners' Equity | ¥6.61B | ¥6.66B | ¥-53M |
| Working Capital | ¥276M | - | - |